Comparing Poly (ADP–Ribose) Polymerase Inhibitors With Standard Chemotherapy inBRCA-Mutated, Recurrent Ovarian Cancer: Lessons Learned From a Negative Trial
Comparing Poly (ADP–Ribose) Polymerase Inhibitors With Standard Chemotherapy inBRCA-Mutated, Recurrent Ovarian Cancer: Lessons Learned From a Negative Trial
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started